antiprotozoals (Merck & Co)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameantiprotozoals (Merck & Co)
Drug Alias Nameapicidin derivatives (Merck & Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsMalariaProtozoan Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsMalariaProtozoan Infections

Other Information

ATC CodeN/A
Related LinksN/A